Evidence map›Paper›PMID 32548750›Full record

ReviewJournal of neurovirology2020

The "Three Italy" of the COVID-19 epidemic and the possible involvement of SARS-CoV-2 in triggering complications other than pneumonia.

Carla Prezioso, Maria Elena Marcocci, Anna Teresa Palamara, Giovanna De Chiara, Valeria Pietropaolo

Abstract readReview
In one paragraph

Review in Journal of neurovirology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Observational
  4. Article
  5. Observational
  6. Article
  7. Computational screening and biochemical analysis ofArabian journal of chemistry · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Stroke in patients infected by the novel coronavirus and its causal mechanisms: A narrative review.Journal of the American College of Emergency Physicians open · 2021
    Article
  12. Article
  13. COVID-19: update of the Italian situation.Journal of neurovirology · 2020
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Carla PreziosoMicrobiology of Chronic Neuro-degenerative Pathologies, IRCSS San Raffaele Pisana, Rome, Italy.
Maria Elena MarcocciDepartment of Public Health and Infectious Diseases, "Sapienza" University, P.le Aldo Moro, 5, 00185, Rome, Italy.
Anna Teresa PalamaraDepartment of Public Health and Infectious Diseases, Laboratory affiliated to Istituto Pasteur Italia - Fondazione Cenci Bolognetti, Sapienza University of Rome, Rome, Italy.
Giovanna De ChiaraInstitute of Translational Pharmacology, National Research Council, Rome, Italy.
Valeria PietropaoloDepartment of Public Health and Infectious Diseases, "Sapienza" University, P.le Aldo Moro, 5, 00185, Rome, Italy. valeria.pietropaolo@uniroma1.it.ORCID 0000-0001-5723-8886

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19), first reported in Wuhan, the capital of Hubei, China, has been associated to a novel coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In March 2020, the World Health Organization declared the SARS-CoV-2 infection a global pandemic. Soon after, the number of cases soared dramatically, spreading across China and worldwide. Italy has had 12,462 confirmed cases according to the Italian National Institute of Health (ISS) as of March 11, and after the "lockdown" of the entire territory, by May 4, 209,254 cases of COVID-19 and 26,892 associated deaths have been reported. We performed a review to describe, in particular, the origin and the diffusion of COVID-19 in Italy, underlying how the geographical circulation has been heterogeneous and the importance of pathophysiology in the involvement of cardiovascular and neurological clinical manifestations.

Indexed as

PandemicsAge FactorsBetacoronavirusCardiovascular DiseasesCoronavirus InfectionsCOVID-19Cytokine Release SyndromeGeographyHumansItalyNervous System DiseasesPneumonia, ViralPrevalenceSARS-CoV-2Severe Acute Respiratory SyndromeSex FactorsCardiovascular manifestationsCOVID-19Italy geographical circulationNeurological implicationsPathophysiologySARS-CoV-2

Identifiers

PMID32548750
PMCPMC7297137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.